WHO denies link between Brazilian vaccines and microcephaly
The World Health Organization issued a note on Feb. 15 ensuring that the rumors associating vaccines for pregnant women with the increase in microcephaly in the country are false. "The vaccines that the organization recommends for pregnant women and that are offered in the Unified Health System (SUS) are safe and effective," the statement said.
The explanation came after a series of rumors about alleged cases of pregnant women who took overdose vaccines or rubella vaccine and had babies with malformation in the head.
In the note, the WHO clarifies that rubella vaccine is not in the calendar of pregnant women and also that its application in women who were still unaware of pregnancy did not result in negative consequences for the fetus.
More than 70 million doses of the immunizing have already been administered to women of childbearing age in Brazil.
According to the Organization, other vaccines, such as against neonatal tetanus and the flu can also be applied in pregnant women safely to the baby.
The Ministry of Health has already denied the rumors and reinforced that pregnant women should continue to take the vaccines intended for this public.
In August 2015, the Ministry began to record the unexpected increase in cases of microcephaly in the Northeast. At the end of November, the folder confirmed that the cases originated in the infection of pregnant women by the Zika virus, which began to have circulation registered in Brazil last year.
In routine operations, via vieolaparoscopic access, the patients have a brief stay in the hospital, on average from 36 to 48 hours. After one week, the patients return to the doctor's office for medical evaluation and guidance for the progression of the diet from liquid to paste. After 30 to 40 days, new medical consultation and nutritionist.
Mammography - Photo Getty Images To reach this technology, scholars have analyzed the genetic material changes in the cancer cells from 600 patients using bioinformatics, a new discipline that uses statistics, mathematics and computer science to solve complex problems in the biology of cancer. After studying, they were able to measure up to 240,000 genome traits in cancer cells for each patient.